Leveraging the power of synthetic biology, OxGEn has developed innovative test systems capable of detecting a range of viruses, bacteria, and fungal diseases with unprecedented speed and efficiency. With a firm commitment to providing specialized product lines, OxGEn aims to establish a foothold in the global market.

Thanks to the generous support of the Innovation and Technology Agency of Georgia (GITA), OxGEn has established a biotechnological production facility in Natakhtari, Georgia. This facility has been equipped with new-generation technology and adheres to the highest international standards, making it ideally suited to meet the demands of modern diagnostic testing.

The GITA grant program was initiated with the financial support of the World Bank on May 22, 2019, to promote innovation and encourage the creation of innovative enterprises that can make a meaningful contribution to Georgia’s economy. The program focuses on micro, small, and medium-sized enterprises that have the potential to develop and present their innovations at the global level, positioning their innovative products in the worldwide market.

We are committed to investing in the latest technology and striving for excellence in our field. We take pride in being recognized as a valuable partner to achieve more in global disease diagnostics efforts.